Table 1.

Patient characteristics at baseline

	All enrolled and treated patients (n = 516)
Sex: male/female	306/210
Age, years	46.2 ± 15
Weight, kg	70.8 ± 11.5
Body mass index, kg/m2	24.6 ± 4.4
Mode of infection: n (%)
Transfusion	180 (34.9)
Injection drug use	155 (30.0)
Other/unknown	181 (35.1)
Serum ALT level (IU/l)	94.2 ± 66.9
Log serum HCV-RNA level	6.2 ± 0.8
HCV RNA > 800,000 IU/ml: n (%)	354 (70.2)
Fibrosis score: n (%)
F1	150 (29.70)
F2	176 (34.85)
F3	135 (26.73
F4	44 (8.72)
Missing	4

ALT: alanine aminotransferase; HCV: hepatitis C virus.